Information Library

Results for: Clinical and marketing materials - North and Central America - United States

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Model-Based Drug Development

    Brochure — October 4, 2011
    Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns.

  • Genomics Fact Sheet

    Brochure — June 17, 2011
    Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area.

  • Strange Bedfellows - Science, Business, Politics, and the Law - Risky Business, Chapter 2

    Hear from the Experts — February 2, 2011
    Chapter Two Excerpt from Risky Business: Managing the Quality of America’s Medicines by Robert A. Rhoades

  • Timely Results - Flu Vaccine

    Case Study — February 2, 2011
    Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season.

  • Global Response HIV

    Case Study — February 1, 2011
    Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients.

  • Acute Coronary Syndrome - Tailored Solutions

    Case Study — February 1, 2011
    Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.

  • Oncology Expertise - Scientific Collaborator for Global Solutions

    Brochure — January 28, 2011
    Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you.

  • QUINTILES AGAIN NAMED TO INFORMATIONWEEK 500

    Press Release — September 15, 2010 - Quintiles has again been named to the InformationWeek 500, the publication’s annual ranking of the nation’s most innovative users of business technology.

  • THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS

    Press Release — June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences